WASHINGTON, March 12 (Reuters) - The blockbuster anti-clotting drug Plavix will carry a new warning about patients who have a poor response to the drug because they do not break it down well, U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback